Sustainable and continuous manufacturing of biotech drug products
| Reference number | |
| Coordinator | Lunds universitet - Institutionen för processteknik och tillämpad biovetenskap |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | August 2024 - October 2025 |
| Status | Completed |
| Venture | Strategic efforts HI |
| Call | Sustainable manufacturing of pharmaceuticals and medical technology products - spring 2024 |
Important results from the project
The project aimed to increase understanding of continuous manufacturing of biologics and its sustainability potential. It achieved its goals through two reports: a technical report identifying practical challenges and a white paper with insights and recommendations. Deeper understanding was gained through industry interviews and workshops that broadened the dialogue and strengthened collaboration. The project laid a solid foundation for continued development.
Expected long term effects
The project is expected to have long-term impact by contributing to strategic decision-making in the field of sustainable pharmaceutical manufacturing. The white paper can serve as a knowledge base for future policy development and international collaboration. New networks have been established that may lead to continued research and innovation initiatives. The growing global interest in continuous manufacturing strengthens the potential for further development and future funding.
Approach and implementation
The project was carried out as planned through three workshops, literature reviews, and interviews with industry representatives. The work was strengthened by student assistants who contributed with additional literature studies and student projects. Some delays occurred due to agreement processes, high workloads, a laboratory relocation, and company downsizing. Thanks to Vinnova’s project extension, all planned activities were successfully completed.